📰 Dose Reduction News
Page 3 - Dose Reduction News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dose Reduction. Real-time updates on events, politics, business and more.
March 31, 2023
The panel discusses the use of quality-of-life clinical trial data in metastatic renal cell carcinoma and how liver and brain metastases affect treatment decision-making.
March 31, 2023
Mehmet Asim Bilen, MD, details how he approaches IO/TKI therapy for patients with renal cell carcinoma with bone metastases.
March 23, 2023
Drs Moshe Ornstein and Mehmet Asim Bilen review updated data from the CheckMate 9ER and CLEAR trials investigating combination treatments for metastatic renal cell carcinoma.
March 23, 2023
Hans Hammers, MD, PhD, explains the situations in which he would choose an ipilimumab/nivolumab treatment regimen over one of the discussed IO/TKI regimens.
May 26, 2022
/PRNewswire/ -- The "Pediatric Imaging Technology Innovation and Growth Opportunities" report has been added to ResearchAndMarkets.coms offering. This study...
May 26, 2022
/PRNewswire/ -- The "Pediatric Imaging Technology Innovation and Growth Opportunities" report has been added to ResearchAndMarkets.coms offering. This study...
May 23, 2022
The "Pediatric Imaging Technology Innovation and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This study highligh
November 5, 2021
/PRNewswire/ -- UCB, a global biopharmaceutical company, today announced new data on its investigational IL-17A and IL-17F inhibitor, bimekizumab, and its TNF...
November 4, 2021
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
November 4, 2021
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...